REGN2810
R2810-ONC-1606
Phase 1 small_molecule completed
Quick answer
REGN2810 for Melanoma is a Phase 1 program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Melanoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed